Atlanta Research and Education Foundation   Report issue

Foundation Phase 4
Founded: Decatur GA United States (1989)

Organization Overview

First Clinical Trial
2005
NCT00214617
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

canagliflozin (invokana) (1 trial)

paroxetine (paxil) (1 trial)

rosuvastatin (crestor) (1 trial)

Drugs in Other Trials (1)

losartan (cozaar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 4)

Hypercholesterolemia (Phase 4)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4